Introduction to Quality Improvement and Patient Safety in Dermatology: Phototherapy
Date of Original Release: March 6, 2020
Date of Expiration: March 6, 2023
Estimated Time of Completion: .5 hours
Quality Improvement provides dermatologists with an opportunity to improve processes and outcomes in the care of patients, increase patient safety, and reduce harm. This module focuses on steps to improve safety and quality in a dermatology practice, initiated from the occurrence of a patient safety event: an in-office phototherapy burn.
Target Audience
Dermatologists and others involved in the delivery of dermatologic care.
Statement of Need
The American Academy of Dermatology bases its CME activities on identified professional practice gaps, the educational needs which underlie these gaps, and emerging clinical research findings as these relate to dermatology. Learners should reflect upon clinical and scientific information presented in this CME activity and determine the need for further study.
Planners
Hillary Johnson-Jahangir, MD, PhD, FAAD
University of Iowa Healthcare
Iowa City, IA
Arielle Rachel Nagler, MD, FAAD
NYU Langone Health
New York, NY
Lauren Orenstein, MD, FAAD
Emory University
Atlanta, GA
Syril Keena Que, MD, MPH, FAAD
Indiana University
Indianapolis, IN
Margo Reeder, MD, FAAD
University of Wisconsin
Madison, WI
Sara Samimi, MD, FAAD
University of Pennsylvania
Philadelphia, PA
Brittney Schultz, MD, FAAD
University of Minnesota
Minneapolis, MN
Gideon Smith, MD, PhD, MPH, FAAD
Massachusetts General Hospital
Boston, MA
Lindsay Chaney Strowd, MD, FAAD
Wake Forest School of Medicine
Winston-Salem, NC
Faculty
Margo Reeder, MD, FAAD
University of Wisconsin
Madison, WI
Karen Sharer, MPH
Manager, Quality Improvement
American Academy of Dermatology
Rosemont, IL
Reviewer
Junko Takeshita, MD, PhD, MSCE, FAAD
University of Pennsylvania
Philadelphia, PA
Staff
Christina Cortese
Senior Instructional Designer
Rosemont, IL
Melinda Keske
Coordinator, Digital Learning
Rosemont, IL
Christine Presta
Associate Director, Digital Learning
Rosemont, IL
Karen Sharer, MPH
Manager, Quality Improvement
Rosemont, IL
Margaret Singer
Education Specialist
Rosemont, IL
Laura Vera
Senior Manager, Performance Measurement & Improvement
Rosemont, IL
Accreditation Statement
The American Academy of Dermatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA PRA Credit Statement
The American Academy of Dermatology designates this Enduring material for a maximum of .50 AMA PRA Category 1 CreditTM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Instructions to Claim Credit
To claim CME credit for this activity, the learner complete the learning activity and the post-activity evaluation.
Disclosures
All other planners, reviewers, faculty/authors, and staff for this activity have no relevant relationship(s) with commercial interest(s).
Conflict Resolution Statement
In accordance with the ACCME Standards for Commercial Support of CME, the American Academy of Dermatology has implemented mechanisms, prior to the planning implementation of this enduring material activity, to identify and mitigate conflicts of interest for all individuals in a position to control the content of this enduring material activity.
Unapproved Use Disclosure
The American Academy of Dermatology requires CME faculty/authors to disclose to learners when products or procedures are being discussed are off-label (not approved for the indications being discussed), unlabeled (not approved for any indications), experimental and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these products/procedures. If you have questions, contact the medical affairs department of the manufacturer for the most recent approval information. Faculty/authors of this activity may be discussing information about pharmaceutical agents that is outside of the U.S. Food and Drug Administration approved labeling.
Disclaimer
The American Academy of Dermatology (AAD) is not responsible for statements made by the author(s). Statement or opinions expressed in this activity reflect the views of the author(s) and do not reflect the official policy of the AAD. The information provided in this CME activity is for continuing education purposes only, is not intended to establish a standard of care, and is not meant to substitute for independent medical judgment of a health provider relative to the diagnostic, management and treatment options of a specific patient’s medical condition.
No Medical Advice
The information in this publication by the American Academy of Dermatology or any third party should not be considered medical advice, and is not intended to replace consultation with a qualified dermatology professional. The American Academy of Dermatology does not answer specific medical questions or refer people to a particular dermatology professional.
Contact Information
For the American Academy of Dermatology Member Resource Center, please call (866) 503-7546.